Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at having imatinib with or without surgery for gastrointestinal stromal tumours (EORTC 62063)
This trial was looking at having surgery with imatinib for gastrointestinal stromal tumours. The trial was for gastrointestinal stromal tumours (GIST) that had spread locally or to the liver.
Doctors often treat GIST that has spread with imatinib, and it stops the cancer coming back for a while. Doctors are always looking for ways to increase the amount of time before the GIST starts to come back. They thought that having surgery, as well as imatinib may help.
The aim of this trial was to see if adding surgery to imatinib could increase the amount of time before GIST started to come back.
Summary of results
This trial was never finished so there are no results available. The researchers were unable to recruit enough patients.
How to join a clinical trial
Dr Michael Leahy
European Organisation for Research and Treatment of Cancer (EORTC)
NIHR Clinical Research Network: Cancer